Literature DB >> 28370176

Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.

Alessandro Soria1, Massimiliano Fabbiani1, Giuseppe Lapadula1, Andrea Gori1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28370176     DOI： 10.1002/hep.29181

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study.

Authors:  Chung-Feng Huang; Ming-Lun Yeh; Ching-I Huang; Po-Cheng Liang; Yi-Hung Lin; Ming-Yen Hsieh; Yu-Ju Wei; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

Review 2.  Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

Authors:  Chung-Feng Huang; Ming-Lung Yu
Journal:  Clin Mol Hepatol       Date:  2019-02-11

3.  Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C.

Authors:  Young-Hwan Ahn; Heirim Lee; Do Young Kim; Hye Won Lee; Su Jong Yu; Young Youn Cho; Jeong Won Jang; Byoung Kuk Jang; Chang Wook Kim; Hee Yeon Kim; Hana Park; Hyo Jung Cho; Bumhee Park; Soon Sun Kim; Jae Youn Cheong
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.